Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins.
about
Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the BrainDevelopment of replication-competent viral vectors for HIV vaccine delivery.Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challengeThe membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly.Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1Rabies virus-based vectors expressing human immunodeficiency virus type 1 (HIV-1) envelope protein induce a strong, cross-reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates.Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector.A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector.A novel, live-attenuated vesicular stomatitis virus vector displaying conformationally intact, functional HIV-1 envelope trimers that elicits potent cellular and humoral responses in mice.Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses.Rhabdovirus-based vectors with human immunodeficiency virus type 1 (HIV-1) envelopes display HIV-1-like tropism and target human dendritic cells.Heterologous exchanges of the glycoprotein and the matrix protein in a Novirhabdovirus.High-level primary CD8(+) T-cell response to human immunodeficiency virus type 1 gag and env generated by vaccination with recombinant vesicular stomatitis viruses.Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type 1 Gag and Env proteinsRecombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge.Rapid pathogenesis induced by a vesicular stomatitis virus matrix protein mutant: viral pathogenesis is linked to induction of tumor necrosis factor alphaVesicular stomatitis virus as a vector to deliver virus-like particles of human norovirus: a new vaccine candidate against an important noncultivable virus.Rhabdovirus-based vaccine platforms against henipavirusesRole of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response.Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen.Vesicular stomatitis virus-simian retrovirus type 2 vaccine protects macaques from detectable infection and B-cell destructionRecombinant rabies virus as potential live-viral vaccines for HIV-1.Nonsegmented negative-strand viruses as vaccine vectors.Development of a novel surrogate virus for human T-cell leukemia virus type 1: inhibition of infection by osteoprotegerin.Newcastle disease virus expressing human immunodeficiency virus type 1 envelope glycoprotein induces strong mucosal and serum antibody responses in Guinea pigsRNA virus vectors: where are we and where do we need to go?Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell LeukemiaBaculovirus as a vaccine vectorIdentification of the block in targeted retroviral-mediated gene transfer.Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome.Infectious Entry Pathway Mediated by the Human Endogenous Retrovirus K Envelope Protein.Host cell factors and functions involved in vesicular stomatitis virus entry.Covalently linked human immunodeficiency virus type 1 gp120/gp41 is stably anchored in rhabdovirus particles and exposes critical neutralizing epitopes.Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol.Characterization of nonpathogenic, live, viral vaccine vectors inducing potent cellular immune responses.Vesicular Stomatitis Virus-Vectored Multi-Antigen Tuberculosis Vaccine Limits Bacterial Proliferation in Mice following a Single Intranasal DoseExpression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vectorReplication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway.Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus.Conjugation of an antibody Fv fragment to a virus coat protein: cell-specific targeting of recombinant polyoma-virus-like particles
P2860
Q28223031-F4C362CB-6381-4AC2-A9EF-FC483627B91CQ33694226-3E642F9D-BA3B-4D6F-8BF3-D1E370D186C2Q33783986-E0C43D5B-7246-4514-B4AB-5792E70425ABQ33798704-A8D0C07D-EC84-4D48-B6C6-BB1CE86040C2Q33826382-91B4AC3D-55FC-4BAF-9B2B-9C4727791952Q33839981-0AE49D8E-BCB9-4856-8017-84C726633950Q33854615-170178EC-23D9-484B-9B82-8C7EF6D0BC8DQ34092753-D5079AA5-9CAB-4ADC-A0A8-B12351FE7FC9Q34172295-C7D370CD-845C-4FC7-A1C5-241A442E40A6Q34317031-3E0D5D86-E83C-4AB2-8EDA-A801212129FEQ34327387-3891FDE9-C87C-4ADA-BD1F-650D7CBF1D33Q34332631-4C3A9074-309E-4CB1-9062-0DD54C6F82AFQ34333167-439A62F7-4131-425F-B89D-3FAD03B5CD3CQ34343020-611C566C-9B86-4D1B-AEF5-051FF971424EQ34647625-C3D24C4C-323F-4817-8FFB-F291E6382F4AQ34717937-ECBA4957-EE44-443E-B7FF-9A93136961ADQ34742846-EFF3B0EC-80D2-4A77-938B-949EECA35561Q34992537-A89D2D4B-8C16-4A83-B7F8-AA556028FAD5Q34998032-8847C294-BE27-466A-A18E-92D7CC8F7AF8Q35076961-79172516-8C29-45A5-A128-F480AD4333A1Q35077051-1C539A6F-54E2-471E-97FE-D1952975CBA9Q35115861-525B524D-8AB0-476F-AB35-1DF2DE09B88AQ35139219-F7FF72E9-6839-457D-854A-833950E5536FQ35155045-3658B1C7-481E-4BD3-A389-DFEE5853A5C8Q35275117-3D890B7E-0B7A-4607-9F63-4C5D79B12738Q36080373-82B6FFA2-8CF4-4DFF-A2A8-82FC6B978322Q36281149-949313F3-0A3B-4C38-A9A6-71DDB4BBD2D1Q36337148-8EAB0109-7764-49E1-8B41-870451D5BE49Q36456085-8CC8BFB3-90E3-4339-8C7E-2DA141B814C9Q36474235-F91C1AF3-6A8F-4C48-B1C1-3E24024FFE46Q36694049-375D763D-7FB4-4593-BC17-4A0E003FCDF3Q37033185-9BB525D4-919D-4E99-AE08-C859E17DCAABQ37059997-999BE3A6-F94C-48AA-B631-CCDE34B05806Q37094160-FF6B411B-580A-42E1-A6EC-6F0B558F0D1FQ37348721-9F3787D0-9572-469C-A55F-F970837B9D11Q37627029-8612C928-5D49-4752-B92D-827CD8D3EF70Q39593656-70047A96-3D23-40BA-8C62-3F845FD60820Q39595495-9CA055A9-7592-4E69-8246-51B4B72BF3E1Q41051042-B4E60E7E-16BC-4346-9568-E1ABCE76DC7CQ41894731-E20286D9-7DC7-42EF-8236-815F14B82539
P2860
Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Specific targeting to CD4+ cel ...... iency virus envelope proteins.
@ast
Specific targeting to CD4+ cel ...... iency virus envelope proteins.
@en
type
label
Specific targeting to CD4+ cel ...... iency virus envelope proteins.
@ast
Specific targeting to CD4+ cel ...... iency virus envelope proteins.
@en
prefLabel
Specific targeting to CD4+ cel ...... iency virus envelope proteins.
@ast
Specific targeting to CD4+ cel ...... iency virus envelope proteins.
@en
P2093
P2860
P1433
P1476
Specific targeting to CD4+ cel ...... ciency virus envelope proteins
@en
P2093
J E Johnson
L Buonocore
M J Schnell
P2860
P304
P407
P577
1997-07-01T00:00:00Z